nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—TSPO—hindlimb—melanoma	0.0128	0.129	CbGeAlD
Eszopiclone—TSPO—appendage—melanoma	0.011	0.111	CbGeAlD
Eszopiclone—TSPO—hair follicle—melanoma	0.00653	0.0657	CbGeAlD
Eszopiclone—GABRA3—neck—melanoma	0.00635	0.0639	CbGeAlD
Eszopiclone—TSPO—blood vessel—melanoma	0.00612	0.0616	CbGeAlD
Eszopiclone—TSPO—neck—melanoma	0.00438	0.0441	CbGeAlD
Eszopiclone—GABRG3—head—melanoma	0.00375	0.0377	CbGeAlD
Eszopiclone—PTGS1—endothelium—melanoma	0.00369	0.0372	CbGeAlD
Eszopiclone—GABRA4—mammalian vulva—melanoma	0.00365	0.0368	CbGeAlD
Eszopiclone—PTGS1—blood vessel—melanoma	0.00341	0.0343	CbGeAlD
Eszopiclone—TSPO—eye—melanoma	0.00326	0.0328	CbGeAlD
Eszopiclone—TSPO—retina—melanoma	0.00323	0.0325	CbGeAlD
Eszopiclone—GABRA5—head—melanoma	0.00288	0.029	CbGeAlD
Eszopiclone—TSPO—skin of body—melanoma	0.00283	0.0285	CbGeAlD
Eszopiclone—GABRA3—head—melanoma	0.00268	0.027	CbGeAlD
Eszopiclone—GABRA4—head—melanoma	0.00261	0.0263	CbGeAlD
Eszopiclone—TSPO—mammalian vulva—melanoma	0.00258	0.026	CbGeAlD
Eszopiclone—Haematuria—Bleomycin—melanoma	0.00245	0.00303	CcSEcCtD
Eszopiclone—Dysphagia—Temozolomide—melanoma	0.00243	0.00301	CcSEcCtD
Eszopiclone—Neuropathy—Docetaxel—melanoma	0.00242	0.003	CcSEcCtD
Eszopiclone—Decreased appetite—Vemurafenib—melanoma	0.00235	0.00291	CcSEcCtD
Eszopiclone—Bronchitis—Temozolomide—melanoma	0.00234	0.00289	CcSEcCtD
Eszopiclone—Stomatitis—Dactinomycin—melanoma	0.00234	0.00289	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Vemurafenib—melanoma	0.00234	0.00289	CcSEcCtD
Eszopiclone—Fatigue—Vemurafenib—melanoma	0.00233	0.00289	CcSEcCtD
Eszopiclone—Constipation—Vemurafenib—melanoma	0.00232	0.00286	CcSEcCtD
Eszopiclone—Lightheadedness—Docetaxel—melanoma	0.00231	0.00285	CcSEcCtD
Eszopiclone—Hypoaesthesia—Bleomycin—melanoma	0.0023	0.00284	CcSEcCtD
Eszopiclone—Dysuria—Temozolomide—melanoma	0.00228	0.00281	CcSEcCtD
Eszopiclone—Pollakiuria—Temozolomide—melanoma	0.00225	0.00278	CcSEcCtD
Eszopiclone—Erectile dysfunction—Temozolomide—melanoma	0.00224	0.00277	CcSEcCtD
Eszopiclone—Depression—Carmustine—melanoma	0.00224	0.00277	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Temozolomide—melanoma	0.00222	0.00275	CcSEcCtD
Eszopiclone—Weight increased—Temozolomide—melanoma	0.00221	0.00274	CcSEcCtD
Eszopiclone—Weight decreased—Temozolomide—melanoma	0.0022	0.00272	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Carmustine—melanoma	0.0022	0.00272	CcSEcCtD
Eszopiclone—Stomatitis—Carmustine—melanoma	0.00219	0.00271	CcSEcCtD
Eszopiclone—GABRG2—head—melanoma	0.00219	0.022	CbGeAlD
Eszopiclone—GABRB2—head—melanoma	0.00219	0.022	CbGeAlD
Eszopiclone—Urinary tract infection—Carmustine—melanoma	0.00218	0.0027	CcSEcCtD
Eszopiclone—Depression—Temozolomide—melanoma	0.00216	0.00268	CcSEcCtD
Eszopiclone—Thrombophlebitis—Docetaxel—melanoma	0.00216	0.00268	CcSEcCtD
Eszopiclone—Hepatitis—Dactinomycin—melanoma	0.00215	0.00266	CcSEcCtD
Eszopiclone—Body temperature increased—Vemurafenib—melanoma	0.00214	0.00265	CcSEcCtD
Eszopiclone—Pharyngitis—Dactinomycin—melanoma	0.00214	0.00264	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Temozolomide—melanoma	0.00213	0.00263	CcSEcCtD
Eszopiclone—Swelling—Docetaxel—melanoma	0.00212	0.00263	CcSEcCtD
Eszopiclone—Stomatitis—Temozolomide—melanoma	0.00211	0.00262	CcSEcCtD
Eszopiclone—Urinary tract infection—Temozolomide—melanoma	0.00211	0.00261	CcSEcCtD
Eszopiclone—Chills—Bleomycin—melanoma	0.00207	0.00256	CcSEcCtD
Eszopiclone—Alopecia—Bleomycin—melanoma	0.00204	0.00252	CcSEcCtD
Eszopiclone—Erythema multiforme—Dactinomycin—melanoma	0.00204	0.00252	CcSEcCtD
Eszopiclone—Hallucination—Carmustine—melanoma	0.00201	0.00248	CcSEcCtD
Eszopiclone—Hypoaesthesia—Carmustine—melanoma	0.00201	0.00248	CcSEcCtD
Eszopiclone—GABRA2—head—melanoma	0.002	0.0201	CbGeAlD
Eszopiclone—Hypersensitivity—Vemurafenib—melanoma	0.00199	0.00247	CcSEcCtD
Eszopiclone—Oedema peripheral—Carmustine—melanoma	0.00199	0.00246	CcSEcCtD
Eszopiclone—Dermatitis bullous—Docetaxel—melanoma	0.00196	0.00242	CcSEcCtD
Eszopiclone—Hepatitis—Temozolomide—melanoma	0.00195	0.00241	CcSEcCtD
Eszopiclone—Asthenia—Vemurafenib—melanoma	0.00194	0.0024	CcSEcCtD
Eszopiclone—Hypoaesthesia—Temozolomide—melanoma	0.00194	0.0024	CcSEcCtD
Eszopiclone—Hallucination—Temozolomide—melanoma	0.00194	0.0024	CcSEcCtD
Eszopiclone—Pharyngitis—Temozolomide—melanoma	0.00193	0.00239	CcSEcCtD
Eszopiclone—Chills—Dactinomycin—melanoma	0.00193	0.00239	CcSEcCtD
Eszopiclone—GABRA1—head—melanoma	0.00193	0.0194	CbGeAlD
Eszopiclone—Oedema peripheral—Temozolomide—melanoma	0.00192	0.00237	CcSEcCtD
Eszopiclone—Pruritus—Vemurafenib—melanoma	0.00192	0.00237	CcSEcCtD
Eszopiclone—Alopecia—Dactinomycin—melanoma	0.0019	0.00235	CcSEcCtD
Eszopiclone—Ill-defined disorder—Bleomycin—melanoma	0.00187	0.00231	CcSEcCtD
Eszopiclone—Anaemia—Bleomycin—melanoma	0.00186	0.0023	CcSEcCtD
Eszopiclone—Diarrhoea—Vemurafenib—melanoma	0.00185	0.00229	CcSEcCtD
Eszopiclone—TSPO—head—melanoma	0.00185	0.0186	CbGeAlD
Eszopiclone—Migraine—Docetaxel—melanoma	0.00184	0.00228	CcSEcCtD
Eszopiclone—Erythema multiforme—Temozolomide—melanoma	0.00184	0.00228	CcSEcCtD
Eszopiclone—Tinnitus—Temozolomide—melanoma	0.00182	0.00225	CcSEcCtD
Eszopiclone—Malaise—Bleomycin—melanoma	0.00181	0.00224	CcSEcCtD
Eszopiclone—Dizziness—Vemurafenib—melanoma	0.00179	0.00221	CcSEcCtD
Eszopiclone—Alopecia—Carmustine—melanoma	0.00178	0.0022	CcSEcCtD
Eszopiclone—Ataxia—Docetaxel—melanoma	0.00176	0.00218	CcSEcCtD
Eszopiclone—Chills—Temozolomide—melanoma	0.00175	0.00216	CcSEcCtD
Eszopiclone—Dehydration—Docetaxel—melanoma	0.00174	0.00215	CcSEcCtD
Eszopiclone—Ill-defined disorder—Dactinomycin—melanoma	0.00174	0.00215	CcSEcCtD
Eszopiclone—Anaemia—Dactinomycin—melanoma	0.00173	0.00214	CcSEcCtD
Eszopiclone—Vomiting—Vemurafenib—melanoma	0.00172	0.00213	CcSEcCtD
Eszopiclone—Alopecia—Temozolomide—melanoma	0.00172	0.00213	CcSEcCtD
Eszopiclone—Dry skin—Docetaxel—melanoma	0.00172	0.00212	CcSEcCtD
Eszopiclone—Myalgia—Bleomycin—melanoma	0.00171	0.00212	CcSEcCtD
Eszopiclone—Chest pain—Bleomycin—melanoma	0.00171	0.00212	CcSEcCtD
Eszopiclone—Rash—Vemurafenib—melanoma	0.00171	0.00211	CcSEcCtD
Eszopiclone—Dermatitis—Vemurafenib—melanoma	0.00171	0.00211	CcSEcCtD
Eszopiclone—Back pain—Carmustine—melanoma	0.0017	0.0021	CcSEcCtD
Eszopiclone—Headache—Vemurafenib—melanoma	0.0017	0.0021	CcSEcCtD
Eszopiclone—Discomfort—Bleomycin—melanoma	0.00169	0.00209	CcSEcCtD
Eszopiclone—Malaise—Dactinomycin—melanoma	0.00169	0.00209	CcSEcCtD
Eszopiclone—Cramp muscle—Docetaxel—melanoma	0.00169	0.00209	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00169	0.00209	CcSEcCtD
Eszopiclone—Dysgeusia—Temozolomide—melanoma	0.00166	0.00205	CcSEcCtD
Eszopiclone—Confusional state—Bleomycin—melanoma	0.00165	0.00205	CcSEcCtD
Eszopiclone—Vision blurred—Carmustine—melanoma	0.00165	0.00205	CcSEcCtD
Eszopiclone—Tremor—Carmustine—melanoma	0.00164	0.00203	CcSEcCtD
Eszopiclone—Anaphylactic shock—Bleomycin—melanoma	0.00164	0.00203	CcSEcCtD
Eszopiclone—Back pain—Temozolomide—melanoma	0.00164	0.00203	CcSEcCtD
Eszopiclone—Infection—Bleomycin—melanoma	0.00163	0.00202	CcSEcCtD
Eszopiclone—Anaemia—Carmustine—melanoma	0.00162	0.00201	CcSEcCtD
Eszopiclone—Dysphagia—Docetaxel—melanoma	0.00162	0.002	CcSEcCtD
Eszopiclone—Agitation—Carmustine—melanoma	0.00161	0.00199	CcSEcCtD
Eszopiclone—Nausea—Vemurafenib—melanoma	0.00161	0.00199	CcSEcCtD
Eszopiclone—Vision blurred—Temozolomide—melanoma	0.0016	0.00198	CcSEcCtD
Eszopiclone—Myalgia—Dactinomycin—melanoma	0.0016	0.00197	CcSEcCtD
Eszopiclone—Tremor—Temozolomide—melanoma	0.00159	0.00197	CcSEcCtD
Eszopiclone—Discomfort—Dactinomycin—melanoma	0.00158	0.00195	CcSEcCtD
Eszopiclone—PTGS1—skin of body—melanoma	0.00158	0.0159	CbGeAlD
Eszopiclone—Ill-defined disorder—Temozolomide—melanoma	0.00157	0.00195	CcSEcCtD
Eszopiclone—Anaemia—Temozolomide—melanoma	0.00157	0.00194	CcSEcCtD
Eszopiclone—Anorexia—Bleomycin—melanoma	0.00156	0.00193	CcSEcCtD
Eszopiclone—Agitation—Temozolomide—melanoma	0.00156	0.00193	CcSEcCtD
Eszopiclone—Angioedema—Temozolomide—melanoma	0.00155	0.00192	CcSEcCtD
Eszopiclone—Malaise—Temozolomide—melanoma	0.00153	0.00189	CcSEcCtD
Eszopiclone—Vertigo—Temozolomide—melanoma	0.00152	0.00188	CcSEcCtD
Eszopiclone—Convulsion—Carmustine—melanoma	0.00152	0.00188	CcSEcCtD
Eszopiclone—Infection—Dactinomycin—melanoma	0.00152	0.00188	CcSEcCtD
Eszopiclone—Hypertension—Carmustine—melanoma	0.00151	0.00187	CcSEcCtD
Eszopiclone—Palpitations—Temozolomide—melanoma	0.0015	0.00185	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00149	0.00185	CcSEcCtD
Eszopiclone—Myalgia—Carmustine—melanoma	0.00149	0.00185	CcSEcCtD
Eszopiclone—Chest pain—Carmustine—melanoma	0.00149	0.00185	CcSEcCtD
Eszopiclone—Anxiety—Carmustine—melanoma	0.00149	0.00184	CcSEcCtD
Eszopiclone—Paraesthesia—Bleomycin—melanoma	0.00147	0.00182	CcSEcCtD
Eszopiclone—Weight increased—Docetaxel—melanoma	0.00147	0.00182	CcSEcCtD
Eszopiclone—Convulsion—Temozolomide—melanoma	0.00147	0.00182	CcSEcCtD
Eszopiclone—Weight decreased—Docetaxel—melanoma	0.00146	0.00181	CcSEcCtD
Eszopiclone—Hypertension—Temozolomide—melanoma	0.00146	0.00181	CcSEcCtD
Eszopiclone—Dyspnoea—Bleomycin—melanoma	0.00146	0.00181	CcSEcCtD
Eszopiclone—Anorexia—Dactinomycin—melanoma	0.00146	0.0018	CcSEcCtD
Eszopiclone—Confusional state—Carmustine—melanoma	0.00144	0.00179	CcSEcCtD
Eszopiclone—Myalgia—Temozolomide—melanoma	0.00144	0.00179	CcSEcCtD
Eszopiclone—Anxiety—Temozolomide—melanoma	0.00144	0.00178	CcSEcCtD
Eszopiclone—PTGS1—mammalian vulva—melanoma	0.00144	0.0145	CbGeAlD
Eszopiclone—Discomfort—Temozolomide—melanoma	0.00143	0.00176	CcSEcCtD
Eszopiclone—Decreased appetite—Bleomycin—melanoma	0.00143	0.00176	CcSEcCtD
Eszopiclone—Infection—Carmustine—melanoma	0.00142	0.00176	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Docetaxel—melanoma	0.00141	0.00175	CcSEcCtD
Eszopiclone—Dry mouth—Temozolomide—melanoma	0.00141	0.00175	CcSEcCtD
Eszopiclone—Stomatitis—Docetaxel—melanoma	0.00141	0.00174	CcSEcCtD
Eszopiclone—Pain—Bleomycin—melanoma	0.0014	0.00174	CcSEcCtD
Eszopiclone—Conjunctivitis—Docetaxel—melanoma	0.0014	0.00173	CcSEcCtD
Eszopiclone—GABRA2—lymph node—melanoma	0.0014	0.0141	CbGeAlD
Eszopiclone—Tachycardia—Carmustine—melanoma	0.0014	0.00173	CcSEcCtD
Eszopiclone—Confusional state—Temozolomide—melanoma	0.0014	0.00173	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00139	0.00172	CcSEcCtD
Eszopiclone—Anaphylactic shock—Temozolomide—melanoma	0.00138	0.00171	CcSEcCtD
Eszopiclone—Infection—Temozolomide—melanoma	0.00137	0.0017	CcSEcCtD
Eszopiclone—Anorexia—Carmustine—melanoma	0.00136	0.00169	CcSEcCtD
Eszopiclone—Epistaxis—Docetaxel—melanoma	0.00136	0.00168	CcSEcCtD
Eszopiclone—Feeling abnormal—Bleomycin—melanoma	0.00135	0.00167	CcSEcCtD
Eszopiclone—Hyperhidrosis—Temozolomide—melanoma	0.00134	0.00165	CcSEcCtD
Eszopiclone—Decreased appetite—Dactinomycin—melanoma	0.00133	0.00165	CcSEcCtD
Eszopiclone—Fatigue—Dactinomycin—melanoma	0.00132	0.00163	CcSEcCtD
Eszopiclone—Anorexia—Temozolomide—melanoma	0.00132	0.00163	CcSEcCtD
Eszopiclone—Pain—Dactinomycin—melanoma	0.00131	0.00162	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Carmustine—melanoma	0.0013	0.00161	CcSEcCtD
Eszopiclone—Urticaria—Bleomycin—melanoma	0.0013	0.00161	CcSEcCtD
Eszopiclone—Rhinitis—Docetaxel—melanoma	0.0013	0.00161	CcSEcCtD
Eszopiclone—Body temperature increased—Bleomycin—melanoma	0.0013	0.0016	CcSEcCtD
Eszopiclone—Hepatitis—Docetaxel—melanoma	0.0013	0.0016	CcSEcCtD
Eszopiclone—Insomnia—Carmustine—melanoma	0.0013	0.0016	CcSEcCtD
Eszopiclone—TSPO—lymph node—melanoma	0.00129	0.013	CbGeAlD
Eszopiclone—Hypoaesthesia—Docetaxel—melanoma	0.00129	0.00159	CcSEcCtD
Eszopiclone—Paraesthesia—Carmustine—melanoma	0.00129	0.00159	CcSEcCtD
Eszopiclone—Pharyngitis—Docetaxel—melanoma	0.00129	0.00159	CcSEcCtD
Eszopiclone—Dyspnoea—Carmustine—melanoma	0.00128	0.00158	CcSEcCtD
Eszopiclone—Oedema peripheral—Docetaxel—melanoma	0.00128	0.00158	CcSEcCtD
Eszopiclone—Somnolence—Carmustine—melanoma	0.00127	0.00157	CcSEcCtD
Eszopiclone—Feeling abnormal—Dactinomycin—melanoma	0.00126	0.00156	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00126	0.00156	CcSEcCtD
Eszopiclone—Insomnia—Temozolomide—melanoma	0.00125	0.00155	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Dactinomycin—melanoma	0.00125	0.00155	CcSEcCtD
Eszopiclone—Decreased appetite—Carmustine—melanoma	0.00124	0.00154	CcSEcCtD
Eszopiclone—Paraesthesia—Temozolomide—melanoma	0.00124	0.00154	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Carmustine—melanoma	0.00124	0.00153	CcSEcCtD
Eszopiclone—Dyspnoea—Temozolomide—melanoma	0.00123	0.00153	CcSEcCtD
Eszopiclone—Somnolence—Temozolomide—melanoma	0.00123	0.00152	CcSEcCtD
Eszopiclone—Erythema multiforme—Docetaxel—melanoma	0.00122	0.00152	CcSEcCtD
Eszopiclone—Pain—Carmustine—melanoma	0.00122	0.00151	CcSEcCtD
Eszopiclone—Constipation—Carmustine—melanoma	0.00122	0.00151	CcSEcCtD
Eszopiclone—Dyspepsia—Temozolomide—melanoma	0.00122	0.00151	CcSEcCtD
Eszopiclone—Body temperature increased—Dactinomycin—melanoma	0.00121	0.0015	CcSEcCtD
Eszopiclone—Abdominal pain—Dactinomycin—melanoma	0.00121	0.0015	CcSEcCtD
Eszopiclone—Hypersensitivity—Bleomycin—melanoma	0.00121	0.0015	CcSEcCtD
Eszopiclone—Decreased appetite—Temozolomide—melanoma	0.0012	0.00149	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Temozolomide—melanoma	0.00119	0.00148	CcSEcCtD
Eszopiclone—Fatigue—Temozolomide—melanoma	0.00119	0.00148	CcSEcCtD
Eszopiclone—Constipation—Temozolomide—melanoma	0.00118	0.00146	CcSEcCtD
Eszopiclone—Pain—Temozolomide—melanoma	0.00118	0.00146	CcSEcCtD
Eszopiclone—Feeling abnormal—Carmustine—melanoma	0.00118	0.00146	CcSEcCtD
Eszopiclone—Asthenia—Bleomycin—melanoma	0.00118	0.00146	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Carmustine—melanoma	0.00117	0.00145	CcSEcCtD
Eszopiclone—Chills—Docetaxel—melanoma	0.00116	0.00144	CcSEcCtD
Eszopiclone—Pruritus—Bleomycin—melanoma	0.00116	0.00144	CcSEcCtD
Eszopiclone—Alopecia—Docetaxel—melanoma	0.00114	0.00142	CcSEcCtD
Eszopiclone—Feeling abnormal—Temozolomide—melanoma	0.00114	0.00141	CcSEcCtD
Eszopiclone—Abdominal pain—Carmustine—melanoma	0.00113	0.0014	CcSEcCtD
Eszopiclone—Body temperature increased—Carmustine—melanoma	0.00113	0.0014	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Temozolomide—melanoma	0.00113	0.0014	CcSEcCtD
Eszopiclone—Hypersensitivity—Dactinomycin—melanoma	0.00113	0.00139	CcSEcCtD
Eszopiclone—Dysgeusia—Docetaxel—melanoma	0.0011	0.00137	CcSEcCtD
Eszopiclone—Urticaria—Temozolomide—melanoma	0.0011	0.00136	CcSEcCtD
Eszopiclone—Asthenia—Dactinomycin—melanoma	0.0011	0.00136	CcSEcCtD
Eszopiclone—Abdominal pain—Temozolomide—melanoma	0.00109	0.00135	CcSEcCtD
Eszopiclone—Body temperature increased—Temozolomide—melanoma	0.00109	0.00135	CcSEcCtD
Eszopiclone—Back pain—Docetaxel—melanoma	0.00109	0.00135	CcSEcCtD
Eszopiclone—Muscle spasms—Docetaxel—melanoma	0.00108	0.00134	CcSEcCtD
Eszopiclone—Hypersensitivity—Carmustine—melanoma	0.00106	0.00131	CcSEcCtD
Eszopiclone—Diarrhoea—Dactinomycin—melanoma	0.00105	0.00129	CcSEcCtD
Eszopiclone—Vomiting—Bleomycin—melanoma	0.00104	0.00129	CcSEcCtD
Eszopiclone—Anaemia—Docetaxel—melanoma	0.00104	0.00129	CcSEcCtD
Eszopiclone—Rash—Bleomycin—melanoma	0.00103	0.00128	CcSEcCtD
Eszopiclone—Dermatitis—Bleomycin—melanoma	0.00103	0.00128	CcSEcCtD
Eszopiclone—PTGS1—head—melanoma	0.00103	0.0104	CbGeAlD
Eszopiclone—Asthenia—Carmustine—melanoma	0.00103	0.00127	CcSEcCtD
Eszopiclone—Hypersensitivity—Temozolomide—melanoma	0.00102	0.00126	CcSEcCtD
Eszopiclone—Palpitations—Docetaxel—melanoma	0.000996	0.00123	CcSEcCtD
Eszopiclone—Asthenia—Temozolomide—melanoma	0.000993	0.00123	CcSEcCtD
Eszopiclone—Diarrhoea—Carmustine—melanoma	0.00098	0.00121	CcSEcCtD
Eszopiclone—Pruritus—Temozolomide—melanoma	0.000979	0.00121	CcSEcCtD
Eszopiclone—Convulsion—Docetaxel—melanoma	0.000977	0.00121	CcSEcCtD
Eszopiclone—Nausea—Bleomycin—melanoma	0.000974	0.00121	CcSEcCtD
Eszopiclone—Hypertension—Docetaxel—melanoma	0.000974	0.0012	CcSEcCtD
Eszopiclone—Vomiting—Dactinomycin—melanoma	0.000973	0.0012	CcSEcCtD
Eszopiclone—Rash—Dactinomycin—melanoma	0.000965	0.00119	CcSEcCtD
Eszopiclone—Myalgia—Docetaxel—melanoma	0.00096	0.00119	CcSEcCtD
Eszopiclone—Chest pain—Docetaxel—melanoma	0.00096	0.00119	CcSEcCtD
Eszopiclone—Dizziness—Carmustine—melanoma	0.000947	0.00117	CcSEcCtD
Eszopiclone—Diarrhoea—Temozolomide—melanoma	0.000947	0.00117	CcSEcCtD
Eszopiclone—Dry mouth—Docetaxel—melanoma	0.000939	0.00116	CcSEcCtD
Eszopiclone—Confusional state—Docetaxel—melanoma	0.000928	0.00115	CcSEcCtD
Eszopiclone—Anaphylactic shock—Docetaxel—melanoma	0.00092	0.00114	CcSEcCtD
Eszopiclone—Dizziness—Temozolomide—melanoma	0.000915	0.00113	CcSEcCtD
Eszopiclone—Infection—Docetaxel—melanoma	0.000914	0.00113	CcSEcCtD
Eszopiclone—Vomiting—Carmustine—melanoma	0.00091	0.00113	CcSEcCtD
Eszopiclone—Nausea—Dactinomycin—melanoma	0.000909	0.00112	CcSEcCtD
Eszopiclone—Rash—Carmustine—melanoma	0.000903	0.00112	CcSEcCtD
Eszopiclone—Dermatitis—Carmustine—melanoma	0.000902	0.00112	CcSEcCtD
Eszopiclone—Tachycardia—Docetaxel—melanoma	0.000898	0.00111	CcSEcCtD
Eszopiclone—Headache—Carmustine—melanoma	0.000897	0.00111	CcSEcCtD
Eszopiclone—Vomiting—Temozolomide—melanoma	0.00088	0.00109	CcSEcCtD
Eszopiclone—Anorexia—Docetaxel—melanoma	0.000877	0.00109	CcSEcCtD
Eszopiclone—Rash—Temozolomide—melanoma	0.000873	0.00108	CcSEcCtD
Eszopiclone—Dermatitis—Temozolomide—melanoma	0.000872	0.00108	CcSEcCtD
Eszopiclone—Headache—Temozolomide—melanoma	0.000867	0.00107	CcSEcCtD
Eszopiclone—Nausea—Carmustine—melanoma	0.000851	0.00105	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000838	0.00104	CcSEcCtD
Eszopiclone—Insomnia—Docetaxel—melanoma	0.000832	0.00103	CcSEcCtD
Eszopiclone—Paraesthesia—Docetaxel—melanoma	0.000826	0.00102	CcSEcCtD
Eszopiclone—Nausea—Temozolomide—melanoma	0.000822	0.00102	CcSEcCtD
Eszopiclone—Dyspnoea—Docetaxel—melanoma	0.00082	0.00101	CcSEcCtD
Eszopiclone—Somnolence—Docetaxel—melanoma	0.000818	0.00101	CcSEcCtD
Eszopiclone—Dyspepsia—Docetaxel—melanoma	0.00081	0.001	CcSEcCtD
Eszopiclone—Decreased appetite—Docetaxel—melanoma	0.0008	0.00099	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Docetaxel—melanoma	0.000795	0.000983	CcSEcCtD
Eszopiclone—Fatigue—Docetaxel—melanoma	0.000793	0.000981	CcSEcCtD
Eszopiclone—Pain—Docetaxel—melanoma	0.000787	0.000973	CcSEcCtD
Eszopiclone—Constipation—Docetaxel—melanoma	0.000787	0.000973	CcSEcCtD
Eszopiclone—Feeling abnormal—Docetaxel—melanoma	0.000758	0.000938	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Docetaxel—melanoma	0.000753	0.000931	CcSEcCtD
Eszopiclone—Abdominal pain—Docetaxel—melanoma	0.000727	0.0009	CcSEcCtD
Eszopiclone—Body temperature increased—Docetaxel—melanoma	0.000727	0.0009	CcSEcCtD
Eszopiclone—PTGS1—lymph node—melanoma	0.00072	0.00725	CbGeAlD
Eszopiclone—Hypersensitivity—Docetaxel—melanoma	0.000678	0.000839	CcSEcCtD
Eszopiclone—Asthenia—Docetaxel—melanoma	0.00066	0.000817	CcSEcCtD
Eszopiclone—Pruritus—Docetaxel—melanoma	0.000651	0.000805	CcSEcCtD
Eszopiclone—Diarrhoea—Docetaxel—melanoma	0.00063	0.000779	CcSEcCtD
Eszopiclone—Dizziness—Docetaxel—melanoma	0.000609	0.000753	CcSEcCtD
Eszopiclone—Vomiting—Docetaxel—melanoma	0.000585	0.000724	CcSEcCtD
Eszopiclone—Rash—Docetaxel—melanoma	0.00058	0.000718	CcSEcCtD
Eszopiclone—Dermatitis—Docetaxel—melanoma	0.00058	0.000717	CcSEcCtD
Eszopiclone—Headache—Docetaxel—melanoma	0.000577	0.000713	CcSEcCtD
Eszopiclone—Nausea—Docetaxel—melanoma	0.000547	0.000676	CcSEcCtD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—MDM2—melanoma	8.28e-05	0.000897	CbGpPWpGaD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	8.26e-05	0.000896	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ABCB1—melanoma	8.21e-05	0.000891	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GPAM—melanoma	8.14e-05	0.000883	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.12e-05	0.000881	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—MDM2—melanoma	7.93e-05	0.00086	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC5A5—melanoma	7.88e-05	0.000854	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—MAPK1—melanoma	7.74e-05	0.000839	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—MDM2—melanoma	7.71e-05	0.000836	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—melanoma	7.67e-05	0.000831	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ACER3—melanoma	7.67e-05	0.000831	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PLCB4—melanoma	7.65e-05	0.000829	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—BRAF—melanoma	7.57e-05	0.000821	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—MDM2—melanoma	7.57e-05	0.00082	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	7.56e-05	0.000819	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	7.53e-05	0.000816	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ABCB1—melanoma	7.51e-05	0.000815	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—FASN—melanoma	7.51e-05	0.000814	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—IL6—melanoma	7.47e-05	0.00081	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—MDM2—melanoma	7.44e-05	0.000806	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	7.34e-05	0.000796	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP17A1—melanoma	7.33e-05	0.000795	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ABCB1—melanoma	7.3e-05	0.000791	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—MDM2—melanoma	7.26e-05	0.000787	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	7.23e-05	0.000784	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	7.21e-05	0.000782	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIP4K2A—melanoma	7.19e-05	0.00078	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC6A11—melanoma	7.19e-05	0.00078	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ABCB1—melanoma	7.17e-05	0.000777	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	7.09e-05	0.000768	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	7.08e-05	0.000768	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—MAPK1—melanoma	7.08e-05	0.000767	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ABCB1—melanoma	7.04e-05	0.000764	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—UGT2B10—melanoma	7.01e-05	0.00076	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MTAP—melanoma	7e-05	0.000758	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	6.92e-05	0.000751	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	6.91e-05	0.000749	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—MAPK1—melanoma	6.88e-05	0.000745	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	6.87e-05	0.000745	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.84e-05	0.000741	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—MAPK1—melanoma	6.75e-05	0.000732	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—HRAS—melanoma	6.75e-05	0.000732	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—MAPK1—melanoma	6.63e-05	0.000719	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	6.63e-05	0.000718	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	6.57e-05	0.000712	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HS3ST5—melanoma	6.52e-05	0.000707	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	6.47e-05	0.000702	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—MAPK1—melanoma	6.44e-05	0.000698	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—MDM2—melanoma	6.34e-05	0.000688	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ACER3—melanoma	6.24e-05	0.000676	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PHGDH—melanoma	6.23e-05	0.000676	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—LUM—melanoma	6.23e-05	0.000676	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—HRAS—melanoma	6.21e-05	0.000673	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP1B1—melanoma	6.17e-05	0.000669	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HPSE—melanoma	6.11e-05	0.000663	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	6.09e-05	0.00066	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	6.04e-05	0.000655	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	6.01e-05	0.000651	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CUBN—melanoma	6e-05	0.000651	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—MAPK1—melanoma	5.93e-05	0.000643	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SDHD—melanoma	5.8e-05	0.000628	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—BSG—melanoma	5.8e-05	0.000628	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CSPG4—melanoma	5.8e-05	0.000628	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—UGT2B10—melanoma	5.71e-05	0.000619	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—HRAS—melanoma	5.68e-05	0.000616	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	5.66e-05	0.000613	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	5.63e-05	0.000611	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GPAM—melanoma	5.61e-05	0.000609	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—ALB—melanoma	5.58e-05	0.000605	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—HRAS—melanoma	5.52e-05	0.000598	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—MAPK1—melanoma	5.42e-05	0.000588	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—HRAS—melanoma	5.42e-05	0.000588	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—HRAS—melanoma	5.33e-05	0.000577	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HS3ST5—melanoma	5.31e-05	0.000575	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	5.3e-05	0.000575	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—MAPK1—melanoma	5.27e-05	0.000571	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.25e-05	0.000569	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	5.2e-05	0.000563	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—MAPK1—melanoma	5.17e-05	0.000561	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—HRAS—melanoma	5.17e-05	0.000561	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ALB—melanoma	5.14e-05	0.000557	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—MAPK1—melanoma	5.08e-05	0.000551	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—MAPK1—melanoma	4.96e-05	0.000538	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PLCB4—melanoma	4.94e-05	0.000536	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	4.85e-05	0.000526	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PLA2G6—melanoma	4.77e-05	0.000517	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—HRAS—melanoma	4.76e-05	0.000516	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	4.7e-05	0.00051	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIP4K2A—melanoma	4.64e-05	0.000504	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC6A11—melanoma	4.64e-05	0.000504	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ALB—melanoma	4.57e-05	0.000495	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	4.54e-05	0.000492	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTAP—melanoma	4.52e-05	0.00049	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ALB—melanoma	4.48e-05	0.000486	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.42e-05	0.000479	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ALB—melanoma	4.41e-05	0.000478	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—HRAS—melanoma	4.35e-05	0.000472	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—MAPK1—melanoma	4.33e-05	0.00047	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	4.3e-05	0.000466	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—VCAN—melanoma	4.29e-05	0.000465	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.27e-05	0.000463	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—HRAS—melanoma	4.23e-05	0.000459	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—HRAS—melanoma	4.15e-05	0.00045	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ACER3—melanoma	4.11e-05	0.000446	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—HRAS—melanoma	4.08e-05	0.000442	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.06e-05	0.00044	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—LUM—melanoma	4.03e-05	0.000437	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PHGDH—melanoma	4.03e-05	0.000437	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PLCB4—melanoma	4.02e-05	0.000436	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—HRAS—melanoma	3.98e-05	0.000432	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HPSE—melanoma	3.95e-05	0.000428	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	3.95e-05	0.000428	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.92e-05	0.000425	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CUBN—melanoma	3.88e-05	0.00042	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC6A11—melanoma	3.78e-05	0.00041	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIP4K2A—melanoma	3.78e-05	0.00041	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—UGT2B10—melanoma	3.76e-05	0.000408	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	3.76e-05	0.000407	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SDHD—melanoma	3.74e-05	0.000406	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—BSG—melanoma	3.74e-05	0.000406	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CSPG4—melanoma	3.74e-05	0.000406	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTAP—melanoma	3.68e-05	0.000399	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GPAM—melanoma	3.63e-05	0.000393	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP17A1—melanoma	3.62e-05	0.000392	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.59e-05	0.00039	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.57e-05	0.000387	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	3.52e-05	0.000382	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HS3ST5—melanoma	3.5e-05	0.000379	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—HRAS—melanoma	3.48e-05	0.000377	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GNA11—melanoma	3.42e-05	0.00037	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—FASN—melanoma	3.34e-05	0.000362	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC5A5—melanoma	3.29e-05	0.000357	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—LUM—melanoma	3.28e-05	0.000355	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PHGDH—melanoma	3.28e-05	0.000355	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HPSE—melanoma	3.21e-05	0.000348	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GNAQ—melanoma	3.18e-05	0.000344	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CD44—melanoma	3.18e-05	0.000344	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CUBN—melanoma	3.16e-05	0.000342	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.11e-05	0.000337	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PLA2G6—melanoma	3.08e-05	0.000334	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.08e-05	0.000334	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SDHD—melanoma	3.05e-05	0.00033	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—BSG—melanoma	3.05e-05	0.00033	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CSPG4—melanoma	3.05e-05	0.00033	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP1B1—melanoma	3.04e-05	0.00033	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GPAM—melanoma	2.95e-05	0.00032	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—VCAN—melanoma	2.77e-05	0.0003	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.69e-05	0.000291	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PLCB4—melanoma	2.65e-05	0.000287	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.62e-05	0.000284	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.53e-05	0.000274	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PLA2G6—melanoma	2.51e-05	0.000272	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ABCB1—melanoma	2.51e-05	0.000272	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIP4K2A—melanoma	2.49e-05	0.00027	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC6A11—melanoma	2.49e-05	0.00027	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTAP—melanoma	2.43e-05	0.000263	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP17A1—melanoma	2.34e-05	0.000253	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PRKCA—melanoma	2.31e-05	0.00025	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.3e-05	0.00025	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ERCC2—melanoma	2.29e-05	0.000248	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	2.27e-05	0.000247	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—VCAN—melanoma	2.25e-05	0.000244	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GNA11—melanoma	2.21e-05	0.000239	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—LUM—melanoma	2.16e-05	0.000234	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PHGDH—melanoma	2.16e-05	0.000234	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—FASN—melanoma	2.16e-05	0.000234	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.13e-05	0.000231	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC5A5—melanoma	2.12e-05	0.00023	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HPSE—melanoma	2.12e-05	0.00023	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CUBN—melanoma	2.08e-05	0.000226	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.06e-05	0.000223	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GNAQ—melanoma	2.05e-05	0.000222	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CD44—melanoma	2.05e-05	0.000222	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—BSG—melanoma	2.01e-05	0.000218	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CSPG4—melanoma	2.01e-05	0.000218	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SDHD—melanoma	2.01e-05	0.000218	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.01e-05	0.000218	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.99e-05	0.000216	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP1B1—melanoma	1.97e-05	0.000213	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPAM—melanoma	1.95e-05	0.000211	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP17A1—melanoma	1.9e-05	0.000206	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.9e-05	0.000206	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.88e-05	0.000203	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.85e-05	0.000201	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CG—melanoma	1.81e-05	0.000196	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GNA11—melanoma	1.8e-05	0.000195	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—FASN—melanoma	1.76e-05	0.000191	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PPARG—melanoma	1.74e-05	0.000189	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.74e-05	0.000188	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC5A5—melanoma	1.73e-05	0.000187	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GNAQ—melanoma	1.67e-05	0.000181	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CD44—melanoma	1.67e-05	0.000181	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PLA2G6—melanoma	1.65e-05	0.000179	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.63e-05	0.000177	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.62e-05	0.000176	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ABCB1—melanoma	1.62e-05	0.000176	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP1B1—melanoma	1.6e-05	0.000174	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CD—melanoma	1.59e-05	0.000172	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALB—melanoma	1.57e-05	0.00017	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PRKCA—melanoma	1.49e-05	0.000162	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—VCAN—melanoma	1.49e-05	0.000161	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ERCC2—melanoma	1.48e-05	0.00016	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.41e-05	0.000153	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CB—melanoma	1.38e-05	0.00015	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTGS2—melanoma	1.37e-05	0.000149	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCB1—melanoma	1.32e-05	0.000143	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP17A1—melanoma	1.25e-05	0.000136	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.22e-05	0.000133	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PRKCA—melanoma	1.21e-05	0.000132	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ERCC2—melanoma	1.2e-05	0.00013	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTEN—melanoma	1.2e-05	0.00013	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GNA11—melanoma	1.18e-05	0.000128	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CG—melanoma	1.17e-05	0.000127	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—FASN—melanoma	1.16e-05	0.000126	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC5A5—melanoma	1.14e-05	0.000124	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PPARG—melanoma	1.13e-05	0.000122	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GNAQ—melanoma	1.1e-05	0.000119	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CD44—melanoma	1.1e-05	0.000119	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP1B1—melanoma	1.06e-05	0.000114	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CD—melanoma	1.03e-05	0.000111	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALB—melanoma	1.01e-05	0.00011	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.97e-06	0.000108	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CG—melanoma	9.5e-06	0.000103	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PPARG—melanoma	9.17e-06	9.94e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CB—melanoma	8.95e-06	9.7e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS2—melanoma	8.86e-06	9.61e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCB1—melanoma	8.69e-06	9.42e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CA—melanoma	8.44e-06	9.15e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CD—melanoma	8.35e-06	9.06e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALB—melanoma	8.25e-06	8.94e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PRKCA—melanoma	8e-06	8.67e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ERCC2—melanoma	7.93e-06	8.6e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTEN—melanoma	7.73e-06	8.38e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CB—melanoma	7.28e-06	7.89e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS2—melanoma	7.21e-06	7.82e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AKT1—melanoma	6.9e-06	7.48e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTEN—melanoma	6.29e-06	6.82e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CG—melanoma	6.27e-06	6.79e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PPARG—melanoma	6.05e-06	6.56e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CD—melanoma	5.51e-06	5.97e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CA—melanoma	5.45e-06	5.91e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALB—melanoma	5.44e-06	5.9e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CB—melanoma	4.8e-06	5.21e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS2—melanoma	4.76e-06	5.16e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AKT1—melanoma	4.45e-06	4.83e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CA—melanoma	4.44e-06	4.81e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTEN—melanoma	4.15e-06	4.5e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AKT1—melanoma	3.63e-06	3.93e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CA—melanoma	2.93e-06	3.17e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AKT1—melanoma	2.39e-06	2.59e-05	CbGpPWpGaD
